Tasimelteon-d is intended for use as an internal standard for the quantification of tasimelteon by GC- or LC-MS. Tasimelteon is a melatonin (MT) receptor agonist. It selectively binds MT and MT receptors (Ks = 0.304 and 0.069 nM, respectively, in NIH3T3 cells expressing the recombinant human receptors) over a panel of 160 additional receptors and enzymes at 10 µM. Tasimelteon inhibits forskolin-induced cAMP accumulation with EC values of 0.79 and 1 nM in NIH3T3 cells expressing the MT or MT receptor, respectively. Formulations containing tasimelteon have been used in the treatment of non-24-hour sleep-wake disorder.
Tasimelteon-d5 is the deuterium labeled Tasimelteon. Tasimelteon is an orally active and selective dual melatonin receptor agonist (DMRA). Tasimelteon has 2.1-4.4 times greater affinity for the MT2 receptor than for the MT1 receptor. Tasimelteon is a circadian regulator and has the potential for Non-24-Hour Sleep-Wake Disorder (Non-24).
IC50&Target
MT2
分子式
C15H14D5NO2
分子量
250.35
CAS号
1962124-51-1
运输条件
Room temperature in continental US; may vary elsewhere.